Is sparsentan (sparsentan) already on the market in the country? Drug Approval and Sales Status

Sparsentan (Sparsentan) is a novel dual receptor antagonist indicated for the treatment of proteinuric chronic kidney disease, specifically in patients with focal segmental glomerulosclerosis (FSGS) and IgA nephropathy. The drug has been approved for marketing in Europe, the United States and other places, and has shown good efficacy in clinical applications in some countries. However, as of now (2025), sparsentan has not been approved for marketing in China, and domestic patients are temporarily unable to purchase the drug directly in local hospitals or pharmacies.

Since it has not yet been launched in the country, patients can only rely on overseas channels to purchase if they need medicine. In foreign markets, the price of the original drug Sparsentan is relatively high, especially in regions such as Europe or the United States. A box of common specifications sells for about 40,000 to 50,000 yuan. Although this price reflects the scarcity and research and development costs of the drug, it is undoubtedly a heavy financial burden for the average patient family.

In order to reduce the cost of treatment, some patients also choose more affordable alternatives. For example, the current market price of the sparsentin version produced by a Lao pharmaceutical factory is approximately RMB 7,000 to RMB 8,000 per box, which is much cheaper than the original drug. These generic drugs are basically the same as the original drugs in terms of ingredients, dosage and efficacy, and are currently one of the main choices for patients with limited economic conditions.

However, it should be noted that the price of overseas drugs is affected by many factors, such as exchange rate fluctuations, international logistics, market supply and demand, etc., so the above quotations are for reference only. Patients should understand the specific conditions of the drug through formal channels before purchasing it, and try to use it under the guidance of a professional doctor to ensure the safety and efficacy of the drug.

Reference materials:https://www.sparsentan.com/